Hypervolemia for Hypertension Pathophysiology: A Population-Based Study

Table 1

Characteristics of the study population ().

	(%)
Gender
Male	1456 (71.6)
Female	578 (28.4)
Age groups
<65	1870 (91.9)
≥65	164 (8.1)
Geographical region
Central Anatolia	323 (15.9)
Mediterranean	141 (6.9)
Aegean	578 (28.4)
East Anatolia	626 (30.8)
Southeastern Anatolia	366 (18)
Measurement time
Morning (<12 o’clock)	649 (31.9)
Afternoon (≥12 o’clock)	1385 (68.1)
Disease history
Healthy	1250 (61.5)
Diabetics	240 (11.8)
Known HT	380 (18.7)
CAD	87 (4.3)
COPD	41 (2)
CKD	47 (2.9)
Anti-HT
ACEi/ARB	96 (4.7)
Beta blockers	50 (2.5)
CCB	18 (0.9)
Diuretics	7 (0.3)

The number of subjects is crude (unadjusted) figures.
HT: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, CKD: chronic kidney disease, ACEi: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, and CCB: calcium channel blockers.